Cargando…

Access to Care and Diagnostic Delays in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry

OBJECTIVE: To determine factors associated with diagnostic delays and outcomes in juvenile dermatomyositis (JDM) in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry (CLR). METHODS: This was a cross‐sectional study of subjects aged 0 to 17 years with JDM enrolled to the CLR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neely, Jessica, Shalen, Julia, Sturrock, Hugh, Kim, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126761/ https://www.ncbi.nlm.nih.gov/pubmed/33932146 http://dx.doi.org/10.1002/acr2.11246

Ejemplares similares

Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry
por: Wu, Eveline Y., et al.
Publicado: (2019)

Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry
por: Neely, Jessica, et al.
Publicado: (2022)

Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry
por: Tory, Heather, et al.
Publicado: (2020)

Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry
por: Weiss, Jenifer E., et al.
Publicado: (2019)

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Beukelman, Timothy, et al.
Publicado: (2021)

Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease
por: Kim, Susan, et al.
Publicado: (2017)

Correction to: Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry
por: Weiss, Jennifer E., et al.
Publicado: (2020)

Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Henderson, Lauren A., et al.
Publicado: (2016)

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
por: Spencer, CH, et al.
Publicado: (2017)

Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry
por: Prahalad, Sampath, et al.
Publicado: (2016)

Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance
por: Sherman, Matthew A., et al.
Publicado: (2023)

Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Mannion, Melissa L., et al.
Publicado: (2022)

Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Hahn, Timothy, et al.
Publicado: (2022)

Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
por: Orandi, A. B., et al.
Publicado: (2017)

Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Hahn, Timothy, et al.
Publicado: (2022)

Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey
por: Shenoi, Susan, et al.
Publicado: (2019)

Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus
por: Ota, Sylvia, et al.
Publicado: (2008)

The childhood arthritis & rheumatology research alliance network registry: demographics and characteristics of the initial 6-month cohort
por: Natter, Marc D, et al.
Publicado: (2012)

Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Roberts, Jordan E., et al.
Publicado: (2022)

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
por: Kimura, Yukiko, et al.
Publicado: (2017)

First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
por: Beukelman, Timothy, et al.
Publicado: (2022)

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
por: Beukelman, Timothy, et al.
Publicado: (2017)

Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
por: Cooper, Jennifer C, et al.
Publicado: (2018)

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
por: Kimura, Yukiko, et al.
Publicado: (2021)

Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat
por: Yildirim-Toruner, Cagri, et al.
Publicado: (2022)

Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry
por: Jatuworapruk, Kanon, et al.
Publicado: (2022)

Initial data from the COVID-19 Global Rheumatology Alliance provider registries
por: Vanjak, Anthony
Publicado: (2020)

Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates
por: Khawaja, Khulood, et al.
Publicado: (2017)

Pres-FINAL-2009: Pediatric rheumatology practitioners experience with biologics in juvenile dermatomyositis: survey results
por: Patwardhan, A, et al.
Publicado: (2013)

A dermatopathic Juvenile Dermatomyositis; An Unexpected Case in Childhood
por: HASSAS YEGANEH, Mehrnoush, et al.
Publicado: (2020)

Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors' reply
por: Gianfrancesco, Milena A
Publicado: (2020)

Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting: Toronto, Canada. 14-17 April 2016
por: Fotis, Lampros, et al.
Publicado: (2016)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest pediatric nephrology consortium and the childhood arthritis and rheumatology research alliance
por: Wenderfer, Scott E., et al.
Publicado: (2015)

Proceedings of the 2018 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting: Denver, CO, USA. 12-15 April 2018
Publicado: (2018)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis—Insights From Other Diseases
por: Hoeppli, Romy E., et al.
Publicado: (2019)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Fashionably Late: A Case of Delayed Cutaneous Manifestations in Juvenile Dermatomyositis
por: Antoine, Maya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fkdjncm162tv80tra5c9d4tvrb